<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="21609">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01754012</url>
  </required_header>
  <id_info>
    <org_study_id>266486</org_study_id>
    <nct_id>NCT01754012</nct_id>
  </id_info>
  <brief_title>European Project on Nutrition in Elderly People</brief_title>
  <acronym>NU-AGE</acronym>
  <official_title>New Dietary Strategies Addressing the Specific Needs of Elderly Population for an Healthy Aging in Europe</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bologna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Commission</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Bologna</source>
  <oversight_info>
    <authority>Italy: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      NU-AGE is a large multidisciplinary consortium (31 partners, from 17 EU countries) involving
      nutritionists, bio-gerontologists, immunologists and molecular biologists from the most
      prestigious institutions in Europe, 5 large food industries, 8 traditional food companies
      and 1 biotech SME, SPES GEIE and CIAA, covering the SME Food Industrial Associations of 13
      European countries and the European Confederation the food and drink industry. NU-AGE aims
      are: 1. to counteract the physical/cognitive decline occurring in the elderly as a
      consequence of the progressive alteration of different organs/systems (immune and
      cardiovascular systems, bone, brain, muscle and intestine) by one year elderly-tailored
      whole diet intervention on 1250 healthy elderly men and women aged 65-79 years (half diet,
      half control) from 5 different EU regions; 2. to assess the effect of the newly designed
      food pyramid specific for 65+ EU citizens on the different organs/systems using a large set
      of biomarkers related to nutrition and aging, with particular attention to the low grade,
      chronic, systemic inflammatory status named inflammageing, a major risk factor for common
      age-related diseases; 3. to perform in a subgroup of 120 subjects in depth studies and high
      throughput &quot;omics&quot; to identify cellular/molecular targets/mechanisms responsible for whole
      diet effect; 4. to perform genetic and epigenetic studies to assess the role of individual
      variability on the response to diet; 5. to adopt an integrative comprehensive approach
      (systems biology) to analyze the whole set of data. The results of dietary intervention will
      be used to develop elderly-tailored prototypes of functional foods and to improve
      traditional foods. The research activity will be accompanied and followed by a strong
      activity of dissemination and industrial exploitation to support EU strategies on
      nutritional recommendations, thus contributing to the implementation of legislation related
      to nutritional and health claims for elderly in Europe.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Inflammatory Response</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Reduction of inflammatory markers after one-year of NU-AGE dietary intervention in elderly.
Measures of inflammatory status and immune health will be evaluated on plasma: C-reactive protein (hsCRP) IL-1Beta, IL-12, INF gamma, IL-6, sIL-6R, IL-1RA, TNFalpha, IL-17, IL-8, IL-10, TGF-beta1, positivity for HCMV.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cognitive Status</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>The following standardized questionnaires will be administered to volunteers pre and post dietary intervention to evaluate cognitive function:
CERAD Neuropsychological Assessment Battery
Domain Specific Tests (GDS, Babcock story Recall, Trail Making Test)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular Health Status</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluation of blood pressure and measure of lipid profile (triglycerides, total cholesterol, HDL-cholesterol, LDL-cholesterol) pre and post dietary intervention on plasma.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin sensitivity</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Glucose, insulin and Hba1C will be measured on plasma pre and post dietary intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver Function Status</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>ASAT, ALAT, GGT and alkaline phosphatase parameters will be measured on plasma samples pre and post dietary intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hormonal Status</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Leptin and adiponectin hormones will be measured on plasma samples pre and post dietary intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional Status</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>The Nutritional status  will be evaluated on plasma measuring vitamin B12 and folate concentrations.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Digestive Health Status</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Questionnaire to assess bowel function, gastrointestinal disturbances and evacuation frequency will be administered to participants pre and post dietary intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone Health Status</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>All participants, pre and post dietary intervention, will undergone DXA exam to evaluate bone mineral density, also 25-OH vitamin D, parathyroid hormone will be measured on plasma samples.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Functioning</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>The following standardized questionnaires will be administered to volunteers pre and post dietary intervention to evaluate physical function:
SPPB
Hand grip test
Gait Speed Test
ADL, IADL
PASE</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes on Cellular and Molecular mechanisms after diet: Immunological Status</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>On a subgroup of 125subjects (pre and post diet), the following of additional analyses on plasma will be performed to evaluate the immunological status of participants:
Expression and responsiveness of Toll-like receptors, measured as production of downstream cytokines (IFN-a, IFN-b, IFN-y, IL12p40, IL12p70, SOCS3)
Expression of co-stimulatory molecules  (CD1, MHC Class II, CD40, CD80, CD86, CD152, CD154, DC1/DC2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes on Cellular and Molecular mechanisms after diet: Epigenetic signature</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>On a subgroup of 120 subjects (pre and post diet), the epigenetic signature will be evaluated through methylation assay on isolated PBMC.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes on Cellular and Molecular mechanisms after diet: biochemical modifications</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>On a subgroup of 120 subjects (pre and post diet), proteasome and immunoproteasome composition and activity will be measured on proteins from isolated PBMC.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transcriptomics</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>On a subgroup of 120 subjects (pre and post diet) a transcriptomics analysis will be performed on mRNA from isolated PBMC by high throughput technologies &quot;omics&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolomics</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>On a subgroup of 120 subjects (pre and post diet) a the metabolic profile will be performed on urine and plasma/serum by high throughput technologies &quot;omics&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metagenomics</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>On a subgroup of 120 subjects (pre and post diet) the functional and compositional analysis of the microbiota will be assessed on feces by high throughput technologies &quot;omics&quot;.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Habitual Diet</measure>
    <time_frame>4 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Over the course of the 1-year intervention period assessment of habitual diet, will be conducted by repeated the 7 days nutritional diary administered in person (month 1 and 12) and 3 days nutritional diary administered at interim time points (months 4-8) by telephone.</description>
  </other_outcome>
  <other_outcome>
    <measure>Genetic profiling</measure>
    <time_frame>Time 0</time_frame>
    <safety_issue>No</safety_issue>
    <description>The genetic profiling of genes involved in inflammageing will be analyzed (only before diet) in order to assess genotype-phenotype and genotype-diet phenotype associations.</description>
  </other_outcome>
  <other_outcome>
    <measure>General Health information</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Information will be collected at month 1 and 12 on smoking status, health status, physical activity levels, alcohol consumption and medication and supplement use, so that these parameters can be added to all statistical analysis models as confounders</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1250</enrollment>
  <condition>Aging</condition>
  <arm_group>
    <arm_group_label>Dietary Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will follow for a year the NU-AGE whole diet approach elderly-specific and will be supplemented with 10micrograms per day of Vitamin D (cholecalciferol) from MCOHealth.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group will follow the habitual diet.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Dietary Intervention</intervention_name>
    <description>nutrient-rich diet and 10micrograms per day of Vitamin D (cholecalciferol) supplement from MCOHealth</description>
    <arm_group_label>Dietary Intervention</arm_group_label>
    <other_name>NU-AGE diet</other_name>
    <other_name>NU-AGE whole diet approach</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  65-79 years old.

          -  Free of clinically diagnosed overt disease for at least 2 years.

          -  Free-living, independent.

        Exclusion Criteria:

          -  &lt;65 or &gt; 79 years old. 

          -  Overt disease such as aggressive cancer or dementia.

          -  Unstable organ failure or organ failure necessitating a special diet. 

          -  Heart failure. 

          -  Renal failure. 

          -  Respiratory failure. 

          -  Liver failure. 

          -  Type 1 diabetes mellitus. 

          -  Chronic use of corticosteroids. 

          -  Recent (previous 2 months) use of antibiotics. 

          -  Recent (previous 3 months) change to habitual medication (e.g statins and thyroxine)
             use

          -  Presence of food allergy/intolerance or disease necessitating a special diet. 

          -  Malnutrition, as diagnosed by body mass index &lt; 18.5 kg/m2. 

          -  Body weight loss of &gt;10% BW within 6 months. 

          -  Presence of frailty (as assessed by the presence of at least three out of five
             criteria according to Fried et al., 2001: unintentional weight loss, self-reported
             exhaustion, weakness (grip strength), slow walking speed, and low physical activity).

          -  Individual unable to give informed consent.

          -  Volunteers showing previously unrecognized illness will also be excluded.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claudio Franceschi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bologna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Claudio Franceschi, MD, PhD</last_name>
    <phone>0039 051 2094743</phone>
    <email>claudio.franceschi@unibo.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aurelia Santoro, PhD</last_name>
    <phone>0039 0512094758</phone>
    <email>aurelia.santoro@unibo.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Auvergne Research Center on Human Nutrition</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63009</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Noel Cano, Md,PhD</last_name>
      <phone>0033 4 73608270</phone>
      <email>noel.cano@clermont.inra.fr</email>
    </contact>
    <contact_backup>
      <last_name>Nathalie Meunier, PhD</last_name>
      <phone>0033 4 73608273</phone>
      <email>nathalie.meunier@clermont.inra.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Elodie Caumon</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Noelle Lyon belgy</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Noel Cano, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nathalie Meunier</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Bologna-Department of Speciality, Diagnostic and Experimental Medicine</name>
      <address>
        <city>Bologna</city>
        <zip>40126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudio Franceschi, MD</last_name>
      <phone>0039 0512094743</phone>
      <email>claudio.franceschi@unibo.it</email>
    </contact>
    <contact_backup>
      <last_name>Aurelia Santoro, phD</last_name>
      <phone>0039 0512094758</phone>
      <email>aurelia.santoro@unibo.it</email>
    </contact_backup>
    <investigator>
      <last_name>Claudio Franceschi, MD,Phd</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aurelia Santoro, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elisa Pini, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Scurti, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elisa Cevenini, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rita Ostan, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Wageningen-Division of Human Nutrition</name>
      <address>
        <city>Wageningen</city>
        <zip>6703 HD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisette De Groot, PhD</last_name>
      <phone>0031317482577</phone>
      <email>Lisette.deGroot@wur.nl</email>
    </contact>
    <contact_backup>
      <last_name>Edith Feskens, PhD</last_name>
      <phone>0031317482220</phone>
      <email>edith.feskens@wur.nl</email>
    </contact_backup>
    <investigator>
      <last_name>Agnes Berendsen</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Esmee Doets</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lisette de Groot, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Edith Feskens</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Warsaw University of Life Science SGGW-WULS-Department of Human Nutrition</name>
      <address>
        <city>Warsaw</city>
        <zip>02-776</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Brzozowska, Dr</last_name>
      <phone>0048 22 59 37 110</phone>
      <email>anna_brzozowska@sggw.pl</email>
    </contact>
    <contact_backup>
      <last_name>Barbara Pietruszka, Dr</last_name>
      <phone>0048 22 59 37 118</phone>
      <email>barbara_pietruszka@sggw.pl</email>
    </contact_backup>
    <investigator>
      <last_name>Anna Szczecińska, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anna Brzozowska, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Barbara Pietruszka, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Nurition-University of East Anglia</name>
      <address>
        <city>Norwich</city>
        <zip>NR4 7TJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Fairweather-Tait, MD</last_name>
      <phone>0044 1603591304</phone>
      <email>s.fairweather-tait@uea.ac.uk</email>
    </contact>
    <contact_backup>
      <last_name>Amy Jennings</last_name>
      <phone>0044 01603591118</phone>
      <email>amy.jennings@uea.ac.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Rachel Gillings</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Susan Fairweather, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amy Jennings</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.nu-age.eu</url>
    <description>NU-AGE project official website</description>
  </link>
  <verification_date>December 2012</verification_date>
  <lastchanged_date>December 21, 2012</lastchanged_date>
  <firstreceived_date>December 9, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Bologna</investigator_affiliation>
    <investigator_full_name>Claudio Franceschi</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Nutrition</keyword>
  <keyword>Dietary intervention</keyword>
  <keyword>Aging</keyword>
  <keyword>Inflammation</keyword>
  <keyword>Elderly</keyword>
  <keyword>Europe</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
